Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients
Open Access
- 14 September 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-2
- https://doi.org/10.1038/s41392-020-00306-4
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patientsScience, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaThe New England Journal of Medicine, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019JCI Insight, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020